A 35-year-old pregnant woman is diagnosed with hyperlipidemia. Her serum concentrations of total cholesterol, LDL cholesterol, and triglyceride are elevated. Her serum concentration of HDL cholesterol is reduced. Her physician decided to prescribe hypolipidemic therapy. Which drug should be avoided in this patient because of a potential fetal risk?
سؤال مجاني 3 من 10 اليوم · اشترك وكمّل بدون حد
اعرض الإجابة
الإجابة والشرح
ادخل لحسابك عشان نحفظ إجاباتك ونوريك أخطاءك.
الإجابة: D. Atorvastatin
Statins (atorvastatin) must be avoided in pregnancy because of potential fetal risk; the cohort's obesity/lipids summary lists pregnant women under the 'avoid in' column for statins. The question asks which drug to avoid, so the statin is the answer; the other agents are not the ones flagged in the sources.
ليش كل خيار صح أو غلط
-
A
ليش غلط
Ezetimibe works by blocking cholesterol absorption in the intestine; in the cohort's drug table, the drug with pregnant women under 'avoid in' is the statin, not ezetimibe.
✓ Endocrine ✳️.pdf · p. 29 -
B
ليش غلط
In the lipid table, fenofibrate's listed caution is renal (eGFR <30), not pregnancy.
✓ view-material.pdf · p. 24 -
D
ليش صح
Atorvastatin is a statin, and the table lists pregnant women under 'avoid in' for statins, so it must be avoided here.
✓ Endocrine ✳️.pdf · p. 29
- المصدر
- Endocrine ✳️.pdf · p. 29
- المحاضرة
- Obesity & Lipids · Endocrinology · Module B
- ظهر في
- Endo bank